Toshihiro Kimura Selected Research

Toshihiro Kimura Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 09/2004
10	Melanoma (Melanoma, Malignant) 09/2021 - 07/2016
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022 - 09/2004
8	Endometrial Neoplasms (Endometrial Cancer) 06/2022 - 09/2008
6	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 06/2010
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2022 - 05/2007
3	Infections 12/2022 - 12/2002
3	Inflammation (Inflammations) 09/2021 - 02/2011
3	Hyperglycemia 05/2016 - 11/2015
3	Carcinoma (Carcinomatosis) 06/2013 - 12/2011
2	Papillomavirus Infections 12/2022 - 09/2004
2	Uterine Cervical Dysplasia 12/2022 - 05/2012
2	Leiomyosarcoma 01/2021 - 01/2020
2	Myasthenia Gravis 11/2018 - 07/2016
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2018 - 07/2016
2	Type 2 Diabetes Mellitus (MODY) 10/2018 - 01/2016
2	Neoplasm Metastasis (Metastasis) 07/2016 - 10/2005
2	Abdominal Obesity 01/2016 - 11/2015
2	Hypertriglyceridemia 01/2016 - 11/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 11/2015
2	Hypertension (High Blood Pressure) 01/2016 - 11/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 10/2012
2	Carcinogenesis 05/2007 - 09/2004
1	Microsatellite Instability 02/2022
1	Postpartum Hemorrhage 09/2021
1	AIDS-Related Complex (ARC) 09/2021
1	Experimental Melanoma 01/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2020
1	Liposarcoma 12/2019
1	Necrosis 12/2019
1	Sclerosing Cholangitis 07/2019
1	Colitis 01/2019

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 06/2021 - 06/2010
5	Immune Checkpoint InhibitorsIBA 09/2021 - 07/2016
5	PlatinumIBA 09/2021 - 09/2012
5	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2004
5	Paclitaxel (Taxol)FDA LinkGeneric 07/2019 - 12/2011
3	AntigensIBA 02/2021 - 01/2020
3	AntibodiesIBA 01/2021 - 07/2016
3	NivolumabIBA 01/2019 - 07/2016
3	Pharmaceutical PreparationsIBA 04/2016 - 01/2007
3	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 05/2012
3	taxaneIBA 06/2013 - 09/2012
3	Messenger RNA (mRNA)IBA 09/2008 - 09/2004
2	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2022 - 01/2021
2	Monoclonal AntibodiesIBA 06/2022 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 09/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 01/2011
2	Peptides (Polypeptides)IBA 02/2021 - 01/2020
2	CytokinesIBA 02/2021 - 01/2020
2	HDL CholesterolIBA 01/2016 - 11/2015
2	CalciumIBA 05/2015 - 01/2007
2	Tumor Biomarkers (Tumor Markers)IBA 11/2012 - 06/2010
2	AnthracyclinesIBA 10/2012 - 05/2012
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2011 - 09/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2011 - 09/2004
1	VaccinesIBA 12/2022
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 06/2022
1	PromegaIBA 02/2022
1	SuspensionsIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 09/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2021
1	Early Growth Response Protein 1IBA 09/2021
1	Cell-Free Nucleic AcidsIBA 06/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2021
1	Interferon-betaIBA 05/2021
1	Interleukin-15 Receptor alpha SubunitIBA 05/2021
1	Interleukin-15 (Interleukin 15)IBA 05/2021
1	Nucleosomes (Nucleosome)IBA 04/2021
1	EpitopesIBA 02/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	monomethylauristatin FIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2020
1	OX40 LigandIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	IonsIBA 01/2020
1	Copper Sulfate (Sulfate, Copper)FDA Link 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	CopperIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	OvalbuminIBA 01/2020
1	DesminIBA 12/2019
1	A 7 (A-7)IBA 12/2019
1	Contrast MediaIBA 12/2019
1	Bevacizumab (Avastin)FDA Link 07/2019
1	ZincIBA 10/2018

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 07/2019 - 06/2011
8	Therapeutics 04/2021 - 01/2007
4	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 12/2011
3	Immunotherapy 02/2021 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2021 - 02/2021
2	Aftercare (After-Treatment) 02/2021 - 05/2012
2	Lung Transplantation 01/2004 - 12/2002
2	Home Parenteral Nutrition 01/2004 - 12/2002
1	Injections 02/2021